Turning 65 in Ontario: the impact of public drug benefit coverage on hospitalizations for acute and chronic disease
Hux JE, Kopp A, Mamdani MM. Healthcare Policy. 2006; 1(3):87-98.
Publications
Prescribing patterns for Alzheimer disease: survey of Canadian family physicians
Hillmer M, Krahn M, Hillmer M, Pariser P, Naglie G. Can Fam Physician. 2006; 52:208-9.
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Hackam DG, Mamdani M, Li P, Redelmeier DA. Lancet. 2006; 367(9508):413-8.
Economic evaluations in the Canadian Common Drug Review
Laupacis A. Pharmacoeconomics. 2006; 24(11):1157-62.
Cardiac valvulopathy associated with pergolide use
Zadikoff C, Rochon P, Lang A. Can J Neurol Sci. 2006; 33(1):27-33.
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. BMJ. 2006; 332(7534):141-5. Epub 2006 Jan 10.
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends
Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Hypertension. 2006; 47(1):22-8. Epub 2005 Dec 12.
Antidepressants, warfarin and the risk of hemorrhage
Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM. J Clin Psychopharmacol. 2005; 25(6):561-4.
The safety of levofloxacin in elderly patients on warfarin
Stroud LF, Mamdani MM, Kopp A, Bell CM. Am J Med. 2005; 118(12):1417.
Beta-blockers for elective surgery in elderly patients: population based, retrospective cohort study
Redelmeier D, Scales D, Kopp A. BMJ. 2005; 331:932. Epub 2005 Oct 6.